Tom Smart

Tom Smart is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as Chief Executive Officer and Board Member at Actym Therapeutics, Inc., where a novel drug modality is being engineered to activate immune responses in tumors. In addition to this role, Smart holds a board member position at RIGImmune Inc. and has previously led Gravitas Therapeutics as Chief Executive Officer and Board Chair, successfully raising financing and acquiring crucial assets. With extensive experience from executive roles at companies such as AnaptysBio, XOMA, and GenVec, Smart has a proven track record in business development, strategic planning, and capital raising, underpinned by an MBA from The University of Chicago Booth School of Business and a BS in Biological Sciences from Cornell University.